Chairpersons: E. Kontou , Chr. Nikolaou , A. Vittoraki
OR17 | QUANTITATIVE MEASUREMENT OF THE TORQUE-TENO VIRUS (TTV) LEVELS AS A BIOMARKER OF IMMUNE FUNCTION IN LUNG TRANSPLANTED PATIENTS
M. Evangelidou
OR18 | PREVALENCE AND DISTRIBUTION OF MYOSITIS-SPECIFIC (MSAs) AND MYOSITIS-ASSOCIATED AUTOANTIBODIES (MAAs) IN PATIENTS WITH SUSPECTED INFLAMMATORY MYOPATHIES
E. Kontou
OR19 | ANTI-PHOSPHOLIPASE A2 RECEPTOR ANTIBODIES AS A DIAGNOSTIC MARKER OF PRIMARY MEMBRANOUS NEPHROPATHY AND COEXISTENCE WITH ANCA
K. Masselou
OR20 | IMPACT OF VACCINATION WITH TOZINAMERAN ON HUMORAL AND CELLULAR IMMUNITY ACTIVATION AMONG KIDNEY TRANSPLANT RECIPIENTS
A. Fylaktou
OR21 | HUMAN LEUKOCYTE ANTIGENS (HLA) CLASS II AND INTERSTITIAL LUNG DISEASE (ILD) ASSOCIATIONS IN PATIENTS WITH SYSTEMIC AUTOIMMUNE RHEUMATIC DISORDERS (SARDS)
V. Kitsiou
OR22 | THE USE OF DONOR-DERIVED CELL FREE DNA IN POST-KIDNEY TRANSPLANT MONITORING
A. Fylaktou
OR23 | THE ROLE OF nTREGS AND THE IL-23/IL-17 AXIS IN LUPUS NEPHRITIS
A. M. Georgiadou
OR24 | GEOGRAPHICAL ORIGIN ESTIMATION OF BONE MARROW DONORS, BASED ON HLA-TYPING WITH MACHINE LEARNING ALGORITHMS, IN GREECE
I. Theodorou
OR25 | THE IMPACT OF HLA-DRB1*03 ALLELE IN A HELLENIC PEDIATRIC ONSET MULTIPLE SCLEROSIS COHORT
Ch. Skarlis